Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Nanobiotix S.A. for the month of May 2025. The filing, dated May 12, 2025, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The company is headquartered in Paris, France, and files annual reports under Form 20-F.
Financial Metrics
The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing acts solely as a conduit for the attached press release.
Material Changes
The filing text does not provide details regarding material changes versus prior periods. Any such information would be contained within the referenced press release (Exhibit 99.1), the content of which is not included in the input text.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the filing text itself. The document indicates that a press release was issued on May 12, 2025, which likely contains these disclosures, but the text of that release is not provided.
Key Facts for Investor Verification
- Verify the content of the press release dated May 12, 2025, referenced as Exhibit 99.1, as the filing itself contains no operational or financial details.
- Confirm the specific nature of the announcement made by Nanobiotix S.A. on this date, as the Form 6-K only confirms its issuance.
- Note that the Chief Financial Officer, Bart Van Rhijn, signed the report on behalf of the registrant.